ONC-783 Clinical Trials (2026): 1 Studies for Advanced Solid Tumor
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 ONC-783 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Advanced Solid Tumor) and 20 total planned enrollment. 1 ONC-783 clinical trial is actively recruiting. Most recent activity: NCT07408258 (Jun 2028).
ONC-783 clinical trials at a glance: phase × recruitment status
| Phase | not yet recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting ONC-783 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07408258 | PKSafety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors | P1 | Advanced Solid Tumor | 20 | Jun 2026 |
All ONC-783 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07408258 | PK | Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors | P1 | not yet recruiting | 20 | OncoC4, Inc. | Jun 2026 |
ONC-783 clinical trials: frequently asked questions
- How many ONC-783 clinical trials are there?
- 1 ONC-783 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are ONC-783 clinical trials recruiting in 2026?
- No active ONC-783 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is ONC-783 being studied for?
- ONC-783 is being studied for Advanced Solid Tumor. The trials are grouped by indication on this page.
- What phase is ONC-783 in?
- ONC-783 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors ONC-783 clinical trials?
- The lead sponsor across the most ONC-783 trials is OncoC4, Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ONC-783as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: